Literature DB >> 27467823

Does the uterus need to be removed to correct uterovaginal prolapse?

Robert E Gutman1.   

Abstract

PURPOSE OF REVIEW: Owing to growing interest in uterine preservation, this evidence-based review compares hysteropexy with hysterectomy during surgery for uterovaginal prolapse. RECENT
FINDINGS: LeFort colpocleisis is preferred over vaginal hysterectomy and total colpocleisis. The majority of studies show no differences in outcomes comparing sacrospinous hysteropexy with vaginal hysterectomy native tissue prolapse repair except for a single randomized controlled trial showing increased apical recurrences with advanced prolapse. Results comparing uterosacral hysteropexy and sacral hysteropexy with hysterectomy native tissue repairs are inconclusive. Potentially better outcomes are reported when laparoscopic hysterectomy (total or supracervical) is performed with sacral colpopexy compared with laparoscopic sacral hysteropexy, but mesh and morcellation risks should be considered. Data comparing vaginal mesh hysteropexy with currently available products with hysterectomy prolapse repairs are lacking but a high-quality study is underway.
SUMMARY: High satisfaction and low reoperation rates can be accomplished using a variety of hysteropexy techniques. The advantages and disadvantages of uterine conservation must be considered when planning uterovaginal prolapse surgery. The type of hysteropexy and possible graft configuration may impact reoperation rates for recurrent prolapse. Vaginal mesh risks must be considered and laparoscopic mesh risks must be balanced with potential difficulty of future hysterectomy if needed.

Mesh:

Year:  2016        PMID: 27467823     DOI: 10.1097/GCO.0000000000000307

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  9 in total

1.  Trends in prolapse surgery in England.

Authors:  Martino Maria Zacche; Sambit Mukhopadhyay; Ilias Giarenis
Journal:  Int Urogynecol J       Date:  2018-08-04       Impact factor: 2.894

2.  A comparison of modified laparoscopic uterine suspension and vaginal hysterectomy with sacrospinous ligament fixation for treating pelvic organ prolapse.

Authors:  Hongxia Zhu; Yixuan Sun; Xuan Zheng
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 3.  Hysterectomy in the Urologist's Practice.

Authors:  Steven J Weissbart; Ariana L Smith
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

4.  Laparoscopic minimally invasive sacrocolpopexy or hysteropexy and transobturator tape combined with native tissue repair of the vaginal compartments in patients with advanced pelvic organ prolapse and incontinence.

Authors:  Ivan Ignjatovic; Milan Potic; Dragoslav Basic; Ljubomir Dinic; Aleksandar Skakic
Journal:  Int Urogynecol J       Date:  2020-09-08       Impact factor: 2.894

Review 5.  Pelvic organ prolapse and sexual function.

Authors:  Brigitte Fatton; Renaud de Tayrac; Vincent Letouzey; Stéphanie Huberlant
Journal:  Nat Rev Urol       Date:  2020-06-17       Impact factor: 14.432

6.  A new operation technique for uterine prolapse: Vaginally-assisted laparoscopic sacrohysteropexy.

Authors:  İlhan Sanverdi; Çetin Kılıççı; Mesut Polat; Enis Özkaya; Sami Gökhan Kılıç; Merve Dizdar; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2017-09-30

7.  A novel bilateral anterior sacrospinous hysteropexy technique for apical pelvic organ prolapse repair via the vaginal route: a cohort study.

Authors:  Gert Naumann; Clara Börner; Lena-Johanna Naumann; Sebastian Schröder; Tanja Hüsch
Journal:  Arch Gynecol Obstet       Date:  2022-03-14       Impact factor: 2.493

8.  How and on whom to perform uterine-preserving surgery for uterine prolapse.

Authors:  Sumin Oh; Myung Jae Jeon
Journal:  Obstet Gynecol Sci       Date:  2022-06-27

9.  Uterus preservation is superior to hysterectomy when performing laparoscopic lateral suspension with mesh.

Authors:  Nikolaus Veit-Rubin; Jean Dubuisson; Florin Constantin; Sören Lange; Isabelle Eperon; Victor Gomel; Jean-Bernard Dubuisson
Journal:  Int Urogynecol J       Date:  2018-06-30       Impact factor: 2.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.